Press release
Beta Blockers Global Market 2023 - Industry Size, Future Insights, Growth Drivers And Top Players
Beta Blockers Market
The Business Research Company's Beta Blockers Global Market Report 2023 identifies rise in the incidence of cardiovascular diseases as the major driver for the Beta Blockers market's growth in the forecast period. The rise in the incidence of cardiovascular diseases is mostly driven by unhealthy diets, poor lifestyles, lack of exercise, tobacco use, and obesity, where beta blockers can help reduce cardiovascular cases by exerting several beneficial effects on the heart and blood vessels. Hence, rising cases of cardiovascular diseases are contributing to the growth of the beta blockers market.
The global beta blockers market size is expected to grow from $8.55 billion in 2022 to $9.16 billion in 2023 at a compound annual growth rate (CAGR) of 7.13%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global beta blockers market size is expected to reach $11.54 billion in 2027 at a CAGR of 5.9%.
Download Free Sample Of Beta Blockers Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=10684&type=smp
Major competitors in the Beta Blockers market are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca PLC, Johnson and Johnson.
A key trend in the Beta Blockers market includes product innovation. Major market players operating on beta blockers market are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in January 2021, Merck, a Germany-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for a medication called VERQUVO (vericiguat). VERQUVO (vericiguat) is a medication indicated for treating heart failure with reduced ejection fraction (HFrEF) in adults. This drug helps to relax and widen blood vessels, reduce strain on the heart, and improve cardiac function.
Read More On The Global Beta Blockers Market Report Here:
https://www.thebusinessresearchcompany.com/report/beta-blockers-global-market-report
The Beta Blockers market is segmented -
• By Type: Non-selective Agents, Selective Agents
• By Indication: Angina Pectoris, Heart Failure, High Blood Pressure, Other Indications
• By Drugs: Betaxolol, Acebutolol, Esmolol, Other Drugs
• By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
• By Application: Cardiac Diseases, Hypertension, Glaucoma, Other Applications
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Beta Blockers market.
The Business Research Company's "Global Beta Blockers Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Beta Blockers Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10684
The Table Of Content For The Beta Blockers Market Include:
1. Executive Summary
2. Beta Blockers Market Characteristics
3. Beta Blockers Market Trends And Strategies
4. Beta Blockers Market - Macro Economic Scenario
5. Beta Blockers Market Size And Growth
………………………….
26. Africa Beta Blockers Market
27. Beta Blockers Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Beta Blockers Market
29. Beta Blockers Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beta Blockers Global Market 2023 - Industry Size, Future Insights, Growth Drivers And Top Players here
News-ID: 3163795 • Views: …
More Releases from The Business research company
Global Gaucher's Disease Market: Major Drivers Reshaping the Future of the Indus …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Gaucher's Disease Industry Market Size Be by 2025?
The valuation of the Gaucher's disease sector has experienced consistent upward movement throughout the preceding years, projected to advance from its 2024 standing of $1.68 billion to reach $1.76 billion by 2025, reflecting a steady compound annual growth…
Rising Global Incidence Of Eye Illnesses Fuels Accelerated Growth In The Eyelid …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Eyelid Scrub Industry Market Size Be by 2025?
The market for eyelid scrubs has experienced substantial expansion lately, poised to increase from $3.7 billion in the year 2024 to $3.98 billion by 2025, reflecting a compound annual growth rate of 7.6%. This upward trajectory during the…
2025-2034 Esophageal Dysphagia Market Outlook: Key Drivers, Emerging Challenges, …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Esophageal Dysphagia Industry Market Size Be by 2025?
Recent years have seen significant expansion within the market concerning esophageal dysphagia, with projections indicating a rise from its 2024 valuation of $2.08 billion to $2.19 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.1%;…
Global Encephalitis Treatment Market Projected to Grow at 5.7% CAGR, Reaching $2 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Encephalitis Treatment Industry Market Size Be by 2025?
The valuation of the encephalitis therapeutics sector has experienced a robust expansion lately, projecting an increase from its 2024 standing of $21.09 billion to $22.17 billion in 2025, reflecting a consistent compound annual growth rate of 5.1%; this…
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…
